Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Capital Expenditures (2023 - 2025)

Historic Capital Expenditures for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to -$425000.0.

  • Bioharvest Sciences' Capital Expenditures rose 1699.22% to -$425000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.1 million, marking a year-over-year increase of 2338.09%. This contributed to the annual value of -$2.8 million for FY2024, which is 9233.38% down from last year.
  • Latest data reveals that Bioharvest Sciences reported Capital Expenditures of -$425000.0 as of Q3 2025, which was up 1699.22% from -$592000.0 recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Capital Expenditures high stood at -$222000.0 for Q1 2024, and its period low was -$1.7 million during Q2 2024.
  • Its 3-year average for Capital Expenditures is -$585222.2, with a median of -$440000.0 in 2023.
  • Over the last 5 years, Bioharvest Sciences' Capital Expenditures had its largest YoY gain of 6533.96% in 2025, and its largest YoY loss of 20810.81% in 2025.
  • Quarter analysis of 3 years shows Bioharvest Sciences' Capital Expenditures stood at -$291000.0 in 2023, then plummeted by 35.05% to -$393000.0 in 2024, then fell by 8.14% to -$425000.0 in 2025.
  • Its Capital Expenditures was -$425000.0 in Q3 2025, compared to -$592000.0 in Q2 2025 and -$684000.0 in Q1 2025.